Damdamon, Bajari D.

HRN: 23-66-01  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2024
AMPICILLIN 1GM (VIAL)
06/30/2024
07/06/2024
IV
400mg
Q6h
PCAP C
Waiting Final Action 
11/28/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/28/2024
12/05/2024
IVTT
390mg
Q6h
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: